Paradigm Research

What Paradigm Research does

Paradigm Research, LLC is a privately held, founder-owned clinical research organization (CRO) founded in 2019 by Meredith Mundy and headquartered in the Cupertino/San Jose, California area. The firm provides project-based clinical research services, including clinical operations and regulatory support, to start-up medical device and biotech companies in the United States.

The company's core offering is delivered through a scalable network model rather than a fixed employee base: it draws on a curated pool of clinical research professionals covering Clinical Operations through Regulatory functions and scales the team to the needs of each client project. There is no platform-plus-modules product architecture; the offering is a single unified clinical research service, supported by a Wix-hosted company website (paradigmcr.net) and a LinkedIn company page as the primary digital touchpoints. No patents, proprietary technology, AI/ML capabilities, or API/SDK surface are evidenced in the input.

Commercially, Paradigm Research operates a professional-services revenue model with quote-based, pay-for-what-you-need pricing and multi-year contracts, explicitly designed to avoid the fixed overhead typical of larger CROs. Go-to-market is direct and relationship-driven, targeting early-stage medical device and biotech sponsors that need to balance speed, quality, and cost. The company is bootstrapped with no disclosed outside investment, parent company, subsidiaries, partnerships, or acquisitions.

Name

Paradigm Research

Legal name

Paradigm Research, LLC

Website

https://paradigmcr.net

Company type

Private

Founded year

2019

Operating status

Operating

Headcount range

1–10 employees

Short description

Paradigm Research, LLC is a privately held, founder-owned clinical research organization providing project-based clinical operations and regulatory services to start-up medical device and biotech companies in the United States, using a scalable professional network and pay-for-what-you-need pricing.

Ownership category

akta.pro rank

Product category

Contract Research Organization (CRO) Services

NAICS

Research and Development in the Physical, Engineering, and Life Sciences (54171)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Management Consulting Services (8742)

akta.pro primary industry

Clinical CROs (Phase I–IV) (HLAGAAAA)

akta.pro secondary industries

Patient Recruitment, Site Feasibility & Trial Enablement CROs (HLAGAAAI), Clinical Site Start-Up & Activation (Regulatory/Ethics/Contracts) (HLAGACAC)

Keywords

• Clinical research services
• Medical device CRO
• Biotech contract research
• Clinical trial management
• Regulatory affairs consulting

Headquarters

HQ city

Cupertino

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales

Revenue model

1. Clinical Research Services: Project-based clinical research services for start-up medical device and biotech companies. Services are scaled to project needs with a flexible network of clinical research professionals. Clients pay only for needed services without traditional CRO overhead.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Core offering

Paradigm Research, LLC is a Clinical Research Organization (CRO) that delivers scalable clinical research services tailored to start-up medical device and biotech companies. Services span Clinical Operations through Regulatory functions and are executed via a flexible network of clinical research professionals, allowing clients to pay only for the services they need on a project-by-project basis without the overhead typical of larger CROs.

Product overview

Paradigm Research is a Clinical Research Organization (CRO) that provides a single unified offering of clinical research services specifically designed for start-up medical device and biotech companies. The company offers scalable clinical research services that can be adjusted to project needs, with a network of clinical research professionals covering Clinical Operations to Regulatory functions. The company does not operate a platform-plus-modules architecture but rather delivers services through a flexible, pay-for-what-you-need model.

Differentiator

Problem solved

Functional benefit

Products and services

• Clinical Research Services Scalable, project-based clinical research organization (CRO) services for start-up medical device and biotech companies, covering Clinical Operations through Regulatory functions. Services are delivered through a flexible network of clinical research professionals that is sized to project needs, with clients paying only for the services they require rather than for full-service CRO overhead.

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators1 record

Recent moves3 records

Broad incumbents

• Medpace: Large, publicly traded CRO with a strong mid-sized biotech and medical device focus. Operates in the same clinical research services category but at significantly larger scale and with a broader portfolio.
• ICON plc: Global, large-scale CRO offering end-to-end clinical development services. Comparable as a CRO competitor for biotech and medical device sponsors, though operating at vastly larger scale with technology-driven delivery.
• IQVIA: Largest global CRO and life sciences services provider with broad clinical operations and regulatory capabilities. Comparable as a CRO competitor but operates at significantly larger scale across all sponsor segments.

Direct peers

• Biorasi: Boutique CRO focused specifically on emerging biotech and small-to-mid sized sponsors, with a flexible engagement model. Highly comparable to Paradigm Research's start-up-focused CRO positioning and project-based delivery.
• CROMSOURCE: Mid-sized European-headquartered CRO serving biotech, medical device, and pharma clients of varying sizes. Comparable in service scope (clinical operations, regulatory, full-service delivery) and mid-market positioning.
• Synteract: Mid-sized CRO that historically focused on emerging and mid-sized biopharma and medical device companies. Similar service scope (clinical operations, regulatory) and similar target customer profile as Paradigm Research.
• Worldwide Clinical Trials: Mid-sized CRO with strong presence in biotech and emerging pharma, offering clinical operations and regulatory services. Comparable in customer segment focus and mid-tier CRO positioning.
• Premier Research: Mid-sized CRO with explicit focus on small and mid-sized biotech, medical device, and specialty pharma sponsors. Directly comparable in serving under-served early-stage sponsors with flexible clinical operations services.
• Celerion: Early-phase clinical research CRO serving biotech and pharma with a network-driven operational model. Comparable in its boutique CRO positioning and clinical operations focus.
• Rho: Mid-sized, full-service CRO with deep roots in serving small and emerging biopharma and medical device sponsors. Comparable to Paradigm in target customer segment (early-stage sponsors) and clinical operations/regulatory service scope.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/paradigm-research-llc/about/?viewAsMember=true

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Paradigm Research